ChemMeta® – What’s New? What’s Next?

ChemMeta® – What’s New? What’s Next?

ChemMeta® – What’s New? What’s Next? 207 265 Ben Gruber

ChemMeta – What’s New?

Our newest ChemMeta release links our inventory of 1,572 active pharmaceutical ingredients to 695 companies that hold New Drug Applications (NDA) or Abbreviated New Drug Applications (ANDA) for those drugs. Both parent and subsidiary companies are represented in the data.

Additionally, we have added distinct modes for displaying ChemMeta content for its inventory of pharmaceuticals and other non-pharmaceutical chemicals (referred to simply as “chemicals”).

ChemMeta – What’s Next?

Coming to ChemMeta in Q3 is the addition of Adverse Event Report System (AERS) data and an all new “AERS Risk Score” for pharmaceutics. Like the GA Score and the data that underlies it, the AERS Risk Score will be interactive and will allow ChemMeta users to sort, filter, and review the underlying AERS data in various ways.